DRREDDY vs FDC: Stock Comparison

Dr Reddys Laboratories Ltd vs FDC Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Dr Reddys Laboratories Ltd is the larger company by market capitalisation. FDC Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Dr Reddys Laboratories Ltd and FDC Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, DRREDDY is more favourable on 3 of 13 scored metrics and FDC on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DRREDDY is the larger company
₹96,194 Cr vs ₹6,606 Cr
P/E Ratio
FDC has a lower P/E
23.92x vs 29.85x
P/B Ratio
DRREDDY has a lower P/B
2.54x vs 2.71x
EPS
DRREDDY has higher earnings per share
₹51.38 vs ₹17.27
Dividend Yield
FDC has a higher dividend yield
2.42% vs 0.66%
Revenue Growth (TTM YoY)
FDC has faster revenue growth
18.9% vs -11.6%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs -86.2%
Qtr Sales Growth
FDC has stronger quarterly sales growth
18.9% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYFDC
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricDRREDDYFDC
Live Price₹1,151.7₹412.95
Day Change-1.25%2.92%
Volume47.51 L96,778
52-Week High₹1,414.9₹527.8
52-Week Low₹1,101₹312.95
Distance from 52W High-18.6%-21.76%

Valuation

MetricDRREDDYFDC
Market Cap₹96,194 Cr₹6,606 Cr
P/E Ratio29.85x23.92x
P/B Ratio2.54x2.71x
EPS₹51.38₹17.27
Book Value₹452.82₹152.62
Dividend Yield0.66%2.42%

Growth

MetricDRREDDYFDC
Revenue Growth (TTM YoY)-11.6%18.9%
EPS Growth (TTM YoY)-86.2%166.8%
Qtr Sales Growth-11.5%18.9%
Qtr Profit Growth-86.1%167%

Profitability & Leverage

MetricDRREDDYFDC
ROE11.2%12.5%
ROCE13%16.7%
Net Margin12.76%12.96%
Operating Margin19.2%15.9%
Debt to Equity0.2x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYFDC
Promoter Holding26.64% 0.01 pp69.66%
FII Holding32.07% 1.01 pp1.4% 1 pp
DII Holding31.74% 1.02 pp6.31% 0.02 pp
Public Holding9.35% 0.02 pp22.63% 0.98 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and FDC Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.